ask="6.59"
ask_size="200"
average_daily_volume="932936"
bid="6.45"
bid_size="500"
book_value="0.05"
change="+0.42"
change_from_200_day_moving_average="1.41"
change_from_50_day_moving_average="0.41"
change_from_52_week_high="-0.98"
change_From_52_week_low="4.84"
change_in_percent="+6.82%"
close="6.58"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.93"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.86"
ex_dividend_date="N/A"
float_shares="42054000"
high="6.75"
high_52_weeks="7.56"
last_trade_date="2/16/2017"
last_trade_price="6.58"
last_trade_size="61044"
last_trade_time="4:00pm"
low="6.35"
low_52_weeks="1.74"
market_capitalization="485.33M"
moving_average_200_day="5.17"
moving_average_50_day="6.17"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="6.50"
open="6.41"
pe_ratio="N/A"
peg_ratio="-0.32"
percent_change_from_200_day_moving_average="+27.17%"
percent_change_from_50_day_moving_average="+6.64%"
percent_change_from_52_week_high="-12.96%"
percent_change_from_52_week_low="+278.16%"
previous_close="6.16"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="114.07"
price_per_sales="20.68"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.88"
stock_exchange="NMS"
symbol="BCRX"
volume="1953443"
weeks_range_52="1.74 - 7.56"
